Mark Vishnepolsky, MD
Nephrology · Las Vegas, NVNPI 1699707463
Payments from drug & device makers
Across 702 payments — averaging $16,045 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$3.9M
- Astrazeneca UK Limited$2.3M
- AstraZeneca$1.8M
- Eli Lilly$961K
- Vertex$956K
- CSL Behring$338K
- plus $1M from 29 others
Across 47 payments — averaging $1017.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Travere Therapeutics, Inc.$37K
- Eli Lilly$11K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$11,263,914 in reported general payments places this provider in the 95th percentile of 125 nephrology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in Las Vegas
- Raj SinghLas Vegas$9.9M
- Samuel KantorLas Vegas$1M
- Jeffrey RyuLas Vegas$422K
- Lawrence LehrnerLas Vegas$239K
- Richard CottieroLas Vegas$220K
- Kamron SaleemLas Vegas$195K
- Mark AdaimyLas Vegas$142K
- Vincent YangLas Vegas$135K
- Prateek SangheraLas Vegas$45K
- Neda HashemiLas Vegas$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.